QL Biotech, an industry leader in high-quality medical diagnostic solutions, proudly presents our ETO Rapid Device - a cutting-edge approach to screening for widespread substances of abuse. Our device is specifically designed for rapid, efficient, and reliable analysis, providing results you can trust. Our ETO Rapid Device meets the highest standards for substance detection with meticulously precision-designed cut-off levels. From Morphine, Methamphetamine, to Synthetic Cannabis and Tricyclic Antidepressants, we cover a comprehensive range of substances. Each substance has a specific cut-off level, measured in nanograms per milliliter (ng/ml), enabling precise identification and assessment. This ensures that every test conducted is both accurate and consistent. The ETO Rapid Device was developed for use with urine samples, keeping in line with common methods of substance detection. The collection process is straightforward, ensuring a smooth experience for both the tester and testee. We understand the importance of reliable results, and our team is dedicated to providing the most accurate and dependable devices on the market. The majority of our products carry the CE marking, which signifies that our devices meet EU safety, health, and environmental protection standards. This certification reflects our commitment to providing products of the highest quality in order to ensure the wellbeing of everyone who uses the ETO Rapid Device.



At QL Biotech, we continually bring innovative solutions in medical diagnostics to the fore. The ETO Rapid Device is a testament to this, offering reliable, accurate results for a wide range of substances of abuse. Trust in QL Biotech to deliver the quality and reliability you need in vital substance abuse screenings. Experience the next generation of diagnostic testing with QL Biotech's ETO Rapid Device.